225 related articles for article (PubMed ID: 25050814)
1. A unique four-hub protein cluster associates to glioblastoma progression.
Simeone P; Trerotola M; Urbanella A; Lattanzio R; Ciavardelli D; Di Giuseppe F; Eleuterio E; Sulpizio M; Eusebi V; Pession A; Piantelli M; Alberti S
PLoS One; 2014; 9(7):e103030. PubMed ID: 25050814
[TBL] [Abstract][Full Text] [Related]
2. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
3. Molecular classification and survival prediction in human gliomas based on proteome analysis.
Iwadate Y; Sakaida T; Hiwasa T; Nagai Y; Ishikura H; Takiguchi M; Yamaura A
Cancer Res; 2004 Apr; 64(7):2496-501. PubMed ID: 15059904
[TBL] [Abstract][Full Text] [Related]
4. Investigation of serum proteome alterations in human glioblastoma multiforme.
Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.
Gimenez M; Marie SK; Oba-Shinjo S; Uno M; Izumi C; Oliveira JB; Rosa JC
BMC Cancer; 2015 Jun; 15():481. PubMed ID: 26108672
[TBL] [Abstract][Full Text] [Related]
6. Proteomic level changes associated with S3I201 treated U87 glioma cells.
Jain R; Atak A; Yeola A; Srivastava S
J Proteomics; 2017 Jan; 150():341-350. PubMed ID: 27565396
[TBL] [Abstract][Full Text] [Related]
7. Biomarker discovery: a proteomic approach for brain cancer profiling.
Khalil AA
Cancer Sci; 2007 Feb; 98(2):201-13. PubMed ID: 17233837
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of gliomas.
Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
[TBL] [Abstract][Full Text] [Related]
9. Proteomics reveals protein phosphatase 1γ as a biomarker associated with Hippo signal pathway in glioma.
Xue J; Sang W; Su LP; Gao HX; Cui WL; Abulajiang G; Wang Q; Zhang J; Zhang W
Pathol Res Pract; 2020 Nov; 216(11):153187. PubMed ID: 32919304
[TBL] [Abstract][Full Text] [Related]
10. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
11. Optical biopsy identification and grading of gliomas using label-free visible resonance Raman spectroscopy.
Zhou Y; Liu CH; Wu B; Yu X; Cheng G; Zhu K; Wang K; Zhang C; Zhao M; Zong R; Zhang L; Shi L; Alfano RR
J Biomed Opt; 2019 Sep; 24(9):1-12. PubMed ID: 31512439
[TBL] [Abstract][Full Text] [Related]
12. Glioma pathophysiology: insights emerging from proteomics.
Deighton RF; McGregor R; Kemp J; McCulloch J; Whittle IR
Brain Pathol; 2010 Jul; 20(4):691-703. PubMed ID: 20175778
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of MEOX2 in gliomas.
Tachon G; Masliantsev K; Rivet P; Petropoulos C; Godet J; Milin S; Wager M; Guichet PO; Karayan-Tapon L
Mod Pathol; 2019 Jun; 32(6):774-786. PubMed ID: 30659268
[TBL] [Abstract][Full Text] [Related]
14. Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.
Popova SN; Bergqvist M; Dimberg A; Edqvist PH; Ekman S; Hesselager G; Ponten F; Smits A; Sooman L; Alafuzoff I
Histopathology; 2014 Feb; 64(3):365-79. PubMed ID: 24410805
[TBL] [Abstract][Full Text] [Related]
15. Experimental validation of 5 in-silico predicted glioma biomarkers.
Towner RA; Jensen RL; Vaillant B; Colman H; Saunders D; Giles CB; Wren JD
Neuro Oncol; 2013 Dec; 15(12):1625-34. PubMed ID: 24158112
[TBL] [Abstract][Full Text] [Related]
16. Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes.
Thanasupawat T; Glogowska A; Pascoe C; Krishnan SN; Munir M; Begum F; Beiko J; Krcek J; Del Bigio MR; Pitz M; Shen Y; Spicer V; Coombs KM; Wilkins J; Hombach-Klonisch S; Klonisch T
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502484
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the expression profile of Dickkopf-1 gene in human glioma and the association with tumor malignancy.
Zhou Y; Liu F; Xu Q; Wang X
J Exp Clin Cancer Res; 2010 Oct; 29(1):138. PubMed ID: 21029453
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of p42.3 in low- and high-grade gliomas.
Wan W; Xu X; Jia G; Li W; Wang J; Ren T; Wu Z; Zhang J; Zhang L; Lu Y
World J Surg Oncol; 2014 Jun; 12():185. PubMed ID: 24927751
[TBL] [Abstract][Full Text] [Related]
20. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Patil V; Mahalingam K
Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
